EN DE

Genetec Technology Bhd (0104) Fair Value & Analysis

Industrials · MY · Market cap 240M MYR

GT Genetec Technology Bhd 0104 · KLSE
Price0.3750 MYR
Fair Value0.1800 MYR
Upside-52.0%
Quality28/100
Watch Genetec Technology Bhd for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Loss-making · -137.5% net margin
Low debt · negative free cash flow
Mixed vs. peers (4/10)
Narrow moat 6/100
Evidence: Low Range 0.1400 MYR – 0.2100 MYR Share as image

Fair value as of: Aug 13, 2026

From 3 valuation models · updated 6 days ago

Fair value updated Aug 13, 2026, revised from 0.2100 MYR to 0.1800 MYR (−14.3%) since Jul 16, 2026. Share price +13.6% over the past month.

Below-average quality, and screening another 52% overvalued on our models.

Fair value for all 35,000+ stocks, review alerts and the diversification check: 14 days of Pro free, no card.

What matters now

  • The price sits above even our optimistic bull case (0.2100 MYR). The favourable scenario is already priced in.
  • Weak quality (28/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

3.73 MYR 0.1550 MYR Fair Value 0.1800 MYR Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range 0.1550 MYR – 3.73 MYR · fair‑value band 0.1400 MYR – 0.2100 MYR · the 0.3750 MYR price screens above the 0.1800 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Genetec Technology Bhd (0104) currently trades at 0.3750 MYR, while our model-based Fair Value estimate is 0.1800 MYR, implying the stock looks roughly 52.0% overvalued today. The Quality Score stands at 28/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).

Trailing-twelve-month revenue stands at 125M MYR. Revenue declined 72.8% year over year. Net debt stands at 58.1M MYR. Fundamentals as of Aug 13, 2026

Our scenario range runs from 0.1400 MYR (bear case) to 0.2100 MYR (bull case); at 0.3750 MYR, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 62% below its 52-week high and 159% above its 52-week low, currently above its 200-day average. For context, the median of 10 Industrials peers we cover trades at -46% fair-value upside, at -52%, 0104 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Gordon GGM 0.1400 MYR 0.1800 MYR 0.2100 MYR 70
DDM Multi-Stage 0.1400 MYR 0.1800 MYR 0.2200 MYR 61
NCAV (Graham) 0.2000 MYR 0.2600 MYR 0.3900 MYR 50
All 3 models by family
Dividend Discount
Gordon GGM 0.1400 MYR 0.1800 MYR 0.2100 MYR 70
DDM Multi-Stage 0.1400 MYR 0.1800 MYR 0.2200 MYR 61
Asset-Based
NCAV (Graham) 0.2000 MYR 0.2600 MYR 0.3900 MYR 50

Widest divergence: Asset-Based (0.2600 MYR) versus Dividend Discount (0.1800 MYR). Highest evidence: Gordon GGM (70).

Notify me when 0104 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 125M MYR
Revenue growth (YoY) -72.8%
Net margin -137%
Return on equity -1,807%
Free cash flow −113M MYR FY2026
Operating margin -78.7%
More key figures
EPS (TTM) -0.2200 MYR
EPS growth (YoY) +53.1%
Net debt 58.1M MYR FY2026

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 28/100

Of which business quality 30 · Market factors (momentum, volatility) 46

Profitability 2
Margins and returns on capital today
Quality Growth 0
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 58
Balance sheet, leverage, solvency risk
Investment 67
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 60
Price trend over the last 3–12 months (market factor)
52W Momentum 17
Distance to the 52-week high (market factor)
Net Issuance 74
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Genetec Technology Berhad, an investment holding company, designs, manufactures, and sells smart automation systems, customized factory automated equipment, and integrated systems in the United States, Europe, the Middle East, Malaysia, Thailand, Mexico, and internationally.

Full company description

Genetec Technology Berhad, an investment holding company, designs, manufactures, and sells smart automation systems, customized factory automated equipment, and integrated systems in the United States, Europe, the Middle East, Malaysia, Thailand, Mexico, and internationally. The company offers assembly solutions, including robotic pick and place, auto fastening, screw driving, dosing, plasma treatment, plastic and metal laser welding, laser marking, servo press, high precision cam driven, and buffer system products; material handling products, such as cartesian robot pick and place integration, robotic integration, auto feed system, and linear feeding system products; and testing and inspection products comprising vision inspection, functional and pressure tests, laser distance measurement, and test integration products. It also provides in-house machining centers; precision tooling jigs and fixtures; aluminium profiles; and engineering services, as well as conceptual design, prototype development, and equipment mass replication. The company serves electric vehicle and battery, automotive, computer peripherals, consumer goods, and healthcare industries. The company was incorporated in 1997 and is headquartered in Bandar Baru Bangi, Malaysia.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Genetec Technology Bhd reported revenue of 125M MYR in FY2026 versus 224M MYR in FY2022, a compound −13.5%/yr. Reported net income was −175M MYR in FY2026.

Growth Quality 11/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2026)
125M MYR
Latest YoY
−43.7%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−24.8%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.2%
Avg. growth/yr (20Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.1%
Revenue −13.5%/yr
FY22 224M MYR
FY23 295M MYR
FY24 278M MYR
FY25 223M MYR
FY26 125M MYR
Net income
FY22 56.4M MYR
FY23 66.6M MYR
FY24 68.9M MYR
FY25 −33.6M MYR
FY26 −175M MYR

0104 screens 52% overvalued. Compare with GE Vernova Inc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Genetec Technology Bhd Fair Value". https://www.fairvalue-calculator.com/stock/0104

Peer Group

Specialty Industrial Machinery · 816 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 28 · Bottom 25%
Fair Value upside −52% · Below median
Return on assets -3% · Bottom 25%
Net margin (TTM) -137% · Bottom 25%
Operating margin (TTM) -79% · Bottom 25%
Revenue growth -73% · Bottom 25%
Dividend yield (TTM) 6.4% · Top 25%

Valuation Multiples vs Specialty Industrial Machinery median · lower = cheaper

P/B 0.20× · Cheaper than 75% of peers
P/S (TTM) 0.47× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 0
FUTURE0 · sector 22
PAST0 · sector 28
HEALTH100 · sector 95
DIVIDEND100 · sector 27

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Industrial Machinery stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
GE Vernova Inc 1GEV €899.80 €186.93 -79%
1SIE 1SIE €275.55 €91.93 -67%
SMNS SMNS C$31.76 C$22.75 -28%
Atlas Copco AB ATCOA kr 202.30 kr 112.59 -44%
Sandvik AB SAND kr 358.60 kr 193.01 -46%
Cummins India Limited CUMMINSIND ₹5,315 ₹1,355 -75%
Bharat Heavy Electricals Limited BHEL ₹425.20 ₹78.13 -82%
Siemens Limited SIEMENS ₹4,019 ₹746.83 -81%
Airtac International Group 1590 1,470 TWD 853.70 TWD -42%
Suzlon Energy Limited SUZLON ₹47.35 ₹26.64 -44%

Compare Genetec Technology Bhd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Genetec Technology Bhd (0104) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of 0.1800 MYR versus a price of 0.3750 MYR, about −52% (overvalued).
What is the fair value of 0104?
Our model-based fair value for Genetec Technology Bhd is 0.1800 MYR (as of Aug 13, 2026), built from audited fundamentals. The current price: 0.3750 MYR.
What is the quality score of 0104?
Genetec Technology Bhd has a Quality Score of 28/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Genetec Technology Bhd (0104)?
Genetec Technology Bhd reported trailing-twelve-month revenue of about 125M MYR (latest available figure, as of Aug 13, 2026).
What is the net profit margin of 0104?
The net profit margin of Genetec Technology Bhd is about -137.5%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Genetec Technology Bhd and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.